6.75
price up icon1.05%   0.07
after-market Dopo l'orario di chiusura: 6.75
loading
Precedente Chiudi:
$6.68
Aprire:
$6.66
Volume 24 ore:
726.79K
Relative Volume:
0.50
Capitalizzazione di mercato:
$1.04B
Reddito:
$53.61M
Utile/perdita netta:
$-142.52M
Rapporto P/E:
-6.0811
EPS:
-1.11
Flusso di cassa netto:
$-141.83M
1 W Prestazione:
+8.17%
1M Prestazione:
-12.68%
6M Prestazione:
-53.25%
1 anno Prestazione:
+8.35%
Intervallo 1D:
Value
$6.48
$6.86
Intervallo di 1 settimana:
Value
$5.98
$6.86
Portata 52W:
Value
$4.25
$16.73

Wave Life Sciences Ltd Stock (WVE) Company Profile

Name
Nome
Wave Life Sciences Ltd
Name
Telefono
617-949-2900
Name
Indirizzo
7 STRAITS VIEW, SINGAPORE
Name
Dipendente
288
Name
Cinguettio
@WAVELifeSci
Name
Prossima data di guadagno
2025-03-04
Name
Ultimi documenti SEC
Name
WVE's Discussions on Twitter

Confronta WVE con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
WVE
Wave Life Sciences Ltd
6.75 961.80M 53.61M -142.52M -141.83M -1.11
Biotechnology icon
ONC
Beone Medicines Ltd Adr
257.00 26.69B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
443.82 114.81B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.282 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
85.54 6.60B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
483.07 65.36B 14.09B 4.50B 2.96B 39.28

Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-29 Iniziato Cantor Fitzgerald Overweight
2025-04-08 Iniziato Wedbush Outperform
2025-02-25 Iniziato Jefferies Buy
2024-10-16 Aggiornamento Raymond James Outperform → Strong Buy
2024-09-27 Ripresa JP Morgan Overweight
2024-09-19 Iniziato B. Riley Securities Buy
2024-09-09 Iniziato JP Morgan Overweight
2024-05-15 Iniziato Wells Fargo Overweight
2023-12-19 Aggiornamento Leerink Partners Market Perform → Outperform
2023-07-05 Iniziato Raymond James Outperform
2023-05-24 Downgrade Jefferies Buy → Hold
2020-12-15 Ripresa H.C. Wainwright Buy
2020-10-23 Iniziato RBC Capital Mkts Sector Perform
2019-12-31 Downgrade SVB Leerink Outperform → Mkt Perform
2019-11-01 Iniziato Guggenheim Buy
2019-07-15 Iniziato Cowen Market Perform
2019-04-17 Reiterato H.C. Wainwright Buy
2018-08-07 Iniziato Stifel Buy
2018-07-23 Iniziato H.C. Wainwright Buy
2018-03-19 Reiterato Mizuho Buy
2017-02-15 Iniziato H.C. Wainwright Buy
2016-11-10 Ripresa Leerink Partners Outperform
2015-12-07 Iniziato JMP Securities Mkt Outperform
2015-12-07 Iniziato Jefferies Buy
2015-12-07 Iniziato Leerink Partners Outperform
2015-12-07 Iniziato Sun Trust Rbsn Humphrey Buy
Mostra tutto

Wave Life Sciences Ltd Borsa (WVE) Ultime notizie

pulisher
Jun 04, 2025

Wave Life Sciences at Jefferies Conference: RNA Innovation Unveiled By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

Wave Life Sciences at Jefferies Conference: RNA Innovation Unveiled - Investing.com Australia

Jun 04, 2025
pulisher
Jun 01, 2025

Risks Still Elevated At These Prices As Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Dive 26% - simplywall.st

Jun 01, 2025
pulisher
May 30, 2025

Nuveen Asset Management LLC Has $6.85 Million Stock Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

May 30, 2025
pulisher
May 29, 2025

Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference | WVE Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference - GlobeNewswire

May 29, 2025
pulisher
May 29, 2025

Wave Life Sciences CEO Reveals Next-Gen RNA Medicine Plans at Major Healthcare Conference - Stock Titan

May 29, 2025
pulisher
May 28, 2025

Wave Life Sciences Announces Appointment Of Dr. Christopher Wright As Chief Medical Officer - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Wave Life Sciences (WVE) Appoints New Chief Medical Officer | WV - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

Wave Life Sciences (WVE) Appoints New Chief Medical Officer | WVE Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

WaVe Life Sciences’ SWOT analysis: RNA editing pioneer faces fierce competition - Investing.com Nigeria

May 28, 2025
pulisher
May 28, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $648,000 Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

May 28, 2025
pulisher
May 28, 2025

Bank of America Corp DE Acquires 160,820 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

May 28, 2025
pulisher
May 27, 2025

Deutsche Bank AG Purchases 25,756 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

May 27, 2025
pulisher
May 23, 2025

Is Wave Life Sciences (WVE) the Best Low Priced Biotech Stock to Buy Now? - MSN

May 23, 2025
pulisher
May 19, 2025

Preclinical data for Wave’s INHIBE GalNAc-siRNA in obesity - BioWorld MedTech

May 19, 2025
pulisher
May 18, 2025

BNP Paribas Financial Markets Increases Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

May 18, 2025
pulisher
May 17, 2025

Wave Life Sciences Ltd. (NASDAQ:WVE) Given Average Rating of “Buy” by Analysts - Defense World

May 17, 2025
pulisher
May 17, 2025

Wave Life Sciences Ltd. (NASDAQ:WVE) Holdings Increased by Northern Trust Corp - Defense World

May 17, 2025
pulisher
May 16, 2025

(WVE) On The My Stocks Page - news.stocktradersdaily.com

May 16, 2025
pulisher
May 15, 2025

FY2025 Earnings Estimate for WVE Issued By Cantor Fitzgerald - Defense World

May 15, 2025
pulisher
May 14, 2025

Raymond James Financial Inc. Takes $157,000 Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

May 14, 2025
pulisher
May 12, 2025

H.C. Wainwright maintains $22 target on WAVE Life Sciences stock - Investing.com Australia

May 12, 2025
pulisher
May 12, 2025

H.C. Wainwright maintains $22 target on WAVE Life Sciences stock By Investing.com - Investing.com India

May 12, 2025
pulisher
May 11, 2025

Wave Life Sciences (NASDAQ:WVE) Stock Rating Lowered by StockNews.com - Defense World

May 11, 2025
pulisher
May 10, 2025

Wave Life Sciences First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

May 10, 2025
pulisher
May 09, 2025

Despite shrinking by US$215m in the past week, Wave Life Sciences (NASDAQ:WVE) shareholders are still up 407% over 3 years - simplywall.st

May 09, 2025
pulisher
May 09, 2025

RBC Cuts Price Target on Wave Life Sciences to $9 From $10, Keeps Sector Perform, Speculative Risk - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

Wave Life Sciences Reports Q1 2025 Financials and Progress - TipRanks

May 09, 2025
pulisher
May 09, 2025

Wave Life Sciences: Q1 Earnings Snapshot - New Haven Register

May 09, 2025
pulisher
May 09, 2025

WAVE Life Sciences Ltd (WVE) Q1 2025 Earnings Call Highlights: Clinical Advancements and ... - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Wave Life Sciences (NASDAQ:WVE) Shares Gap Down Following Weak Earnings - Defense World

May 09, 2025
pulisher
May 09, 2025

Decoding WAVE Life Sciences Ltd (WVE): A Strategic SWOT Insight - GuruFocus

May 09, 2025
pulisher
May 08, 2025

Transcript : Wave Life Sciences Ltd., Q1 2025 Earnings Call, May 08, 2025 - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Wave Life Sciences Ltd earnings missed by $0.04, revenue fell short of estimates - Investing.com Nigeria

May 08, 2025
pulisher
May 08, 2025

Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update | WVE Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates - Yahoo

May 08, 2025
pulisher
May 08, 2025

Wave Life Sciences (WVE) Misses Revenue Estimates, Advances Clinical Trials | WVE Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Wave Life Sciences Reports Q1 2025 Financial Results - TipRanks

May 08, 2025
pulisher
May 08, 2025

WAVE LIFE SCIENCES Earnings Results: $WVE Reports Quarterly Earnings - Nasdaq

May 08, 2025
pulisher
May 08, 2025

Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 08, 2025
pulisher
May 08, 2025

Earnings Flash (WVE) Wave Life Sciences Reports Q1 Revenue $9.2M, vs. FactSet Est of $11.9M - marketscreener.com

May 08, 2025

Wave Life Sciences Ltd Azioni (WVE) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Wave Life Sciences Ltd Azioni (WVE) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
HENRY CHRISTIAN O
Director
Mar 20 '25
Sale
9.77
10,500
102,574
16,115
$1.15
price down icon 0.86%
$580.59
price up icon 1.24%
$308.00
price up icon 0.88%
$36.54
price up icon 1.27%
$4.8111
price up icon 1.29%
$483.07
price down icon 0.38%
Capitalizzazione:     |  Volume (24 ore):